OSR Holdings, Inc. 8-K

What Happened
OSR Holdings, Inc. (OSRH) filed an 8-K (Item 5.02) reporting that its Board approved the appointment of Yeiseok Kim as Chief Operating Officer, effective April 16, 2026. The appointment was approved on March 26, 2026. Mr. Kim, age 36, previously served as a Senior Analyst at OSR Holdings Co., Ltd. (a subsidiary) from 2020–2025 and holds a Korean medical license (2019), a BA in Environmental Science from Seoul National University (2013), and an MS in Medicine from Jeonbuk National University (2019).

Key Details

• Effective date: April 16, 2026; Board approval: March 26, 2026.
• Compensation: base salary of KRW 240,000,000 per year, participation in the company’s equity-based compensation plan (as determined by the Compensation Committee), and customary executive benefits.
• Employment arrangement: Amended employment agreement entered with OSR Holdings Co., Ltd. reflecting the increased annual compensation.
• No related-party issues disclosed: no family relationships with other officers/directors and no material transactions requiring disclosure under Item 404(a) of Regulation S-K.

Why It Matters
This is a material executive change: the company has a new COO with medical expertise and experience in cross-border healthcare investment and pharmaceutical licensing, which aligns with OSR’s healthcare-related activities. The compensation package increases the company’s executive payroll obligations and includes equity participation, which could modestly affect future equity dilution or compensation expense. The filing notes no related-party concerns, reducing governance risk from this appointment.